Patents by Inventor Susanne Parke

Susanne Parke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8349820
    Abstract: The invention relates to the use, optionally together with oral contraception, of estradiol valerate or 17?-estradiol in combination with 17?-cyanomethyl-17-?-hydroxyestra-4,9-dien-3-one (dienogest) in a multistage or single-stage combination preparation for oral therapy to maintain and/or increase feminine libido. The total number of daily dose units of the multistage combination and of a pharmaceutically harmless placebo or a single-stage combination and optionally the pharmaceutically harmless placebo-containing or placebo- and hormone-free daily dose units amounts to 28 daily dose units.
    Type: Grant
    Filed: October 17, 2007
    Date of Patent: January 8, 2013
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Susan Zeun, Holger Zimmermann, Susanne Parke
  • Publication number: 20080125401
    Abstract: The invention relates to the use, optionally together with oral contraception, of estradiol valerate or 17?-estradiol in combination with 17?-cyanomethyl-17-?-hydroxyestra-4,9-dien-3-one (dienogest) in a multistage or single-stage combination preparation for oral therapy to maintain and/or increase feminine libido. The total number of daily dose units of the multistage combination and of a pharmaceutically harmless placebo or a single-stage combination and optionally the pharmaceutically harmless placebo-containing or placebo- and hormone-free daily dose units amounts to 28 daily dose units.
    Type: Application
    Filed: October 17, 2007
    Publication date: May 29, 2008
    Inventors: Susan Zeun, Holger Zimmermann, Susanne Parke